Secondary |
Chronic Obstructive Pulmonary Disease |
22.2% |
Osteoporosis |
7.7% |
Product Used For Unknown Indication |
7.7% |
Sedation |
7.7% |
Cardiac Disorder |
6.8% |
Hypertension |
6.0% |
Alcohol Withdrawal Syndrome |
5.1% |
Coronary Artery Disease |
5.1% |
Atrial Fibrillation |
4.3% |
Prophylaxis |
4.3% |
Mucous Membrane Disorder |
3.4% |
Tachyarrhythmia |
3.4% |
Arthritis |
2.6% |
Dyspnoea |
2.6% |
Hypokalaemia |
2.6% |
Blood Glucose |
1.7% |
Diabetes Mellitus |
1.7% |
Evidence Based Treatment |
1.7% |
Fluid Replacement |
1.7% |
Infection |
1.7% |
|
Toxic Epidermal Necrolysis |
57.1% |
Flank Pain |
14.3% |
Stridor |
14.3% |
Suicide Attempt |
14.3% |
|
Concomitant |
Product Used For Unknown Indication |
25.0% |
Rheumatoid Arthritis |
17.8% |
Osteoporosis |
10.5% |
Hypertension |
9.6% |
Drug Use For Unknown Indication |
8.4% |
Pain |
5.1% |
Coronary Artery Disease |
2.8% |
Constipation |
2.0% |
Prophylaxis Against Transplant Rejection |
2.0% |
Prophylaxis |
1.9% |
Epilepsy |
1.8% |
Renal Transplant |
1.8% |
Osteoporosis Prophylaxis |
1.7% |
Parkinson's Disease |
1.7% |
Bladder Disorder |
1.7% |
Crohn's Disease |
1.6% |
Convulsion |
1.2% |
Depression |
1.2% |
Polyarthritis |
1.1% |
Sleep Disorder |
1.1% |
|
Vomiting |
10.6% |
Progressive Multifocal Leukoencephalopathy |
8.7% |
White Blood Cell Count Decreased |
8.7% |
Urinary Tract Infection |
7.7% |
Pain In Extremity |
5.8% |
Pyrexia |
5.8% |
Sepsis |
5.8% |
Tachycardia |
4.8% |
Transplant Rejection |
4.8% |
Weight Decreased |
4.8% |
Hypertension |
3.8% |
Intervertebral Disc Protrusion |
3.8% |
Psychotic Disorder |
3.8% |
Ureteral Stent Removal |
3.8% |
Convulsion |
2.9% |
Cytomegalovirus Infection |
2.9% |
Drug Interaction |
2.9% |
Kidney Transplant Rejection |
2.9% |
Nail Discolouration |
2.9% |
Rash |
2.9% |
|
Interacting |
Drug Use For Unknown Indication |
38.5% |
Product Used For Unknown Indication |
15.4% |
Dementia Alzheimer's Type |
7.7% |
Epilepsy |
7.7% |
Gastritis |
7.7% |
Hyperthyroidism |
7.7% |
Osteoporosis |
7.7% |
Parkinson's Disease |
7.7% |
|
Drug Interaction |
50.0% |
Restlessness |
50.0% |
|